Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

3.18
BATS BZX Real-Time Price
As of 1:33pm ET
 +0.07 / +2.25%
Today’s Change
2.42
Today|||52-Week Range
6.10
+10.42%
Year-to-Date
No recent news for Dicerna Pharmaceuticals Inc.

Today’s Trading

Previous close3.11
Today’s open3.14
Day’s range3.14 - 3.20
Volume1,280
Average volume (3 months)147,568
Market cap$64.7M
Dividend yield--
Data as of 1:33pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+7.12%
Earnings growth (this year)+19.40%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.33%
P/E ratioNM
Price/Sales202.28
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
IPCIIntellipharmaceutics...+0.08+4.01%
AGLEAeglea Bio Therapeut...-0.10-2.63%
SNSSSunesis Pharmaceutic...-0.05-1.68%
NOVNNovan Inc-0.07-1.66%
Data as of 1:20pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$295.0K
Annual profit (last year)-$59.5M
Net profit margin-20,173.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior Vice President-
Operations
David W. Miller
Corporate headquarters
Cambridge, Massachusetts

Forecasts